74 results
Causes of SVC Syndrome - Differential Diagnosis Framework
 • Benign (15-40%): Thrombosis (aka catheter-associated), Goiter, Fibrosing
Malignant (60-85%): SCLC ... , NSCLC, NHL, Germ
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival #EBM ... #Osimertinib #NSCLC ... #Survival #NEJM
Contraindications to Resection of Non Small cell lung cancer(NSCLC).
#NSCLC #lungcancer #surgery
cell lung cancer(NSCLC ... #NSCLC #lungcancer
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer #EBM ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
#EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
Causes of Superior Vena Cava (SVC) Syndrome 
Malignant Causes (2/3 of cases)
 - 95%
Cancer - NSCLC ... common) - SCLC
EBUS NSCLC Lymph Node Staging Algorithm

#EBUS #NSCLC #Staging #Algorithm #pulmonary #diagnosis
EBUS NSCLC Lymph ... Algorithm #EBUS #NSCLC
Small Cell Lung Cancer (SCLC) Staging
SCLC has 2 stages: 'Limited' or 'Extensive'
Limited = disease fitting into
Cell Lung Cancer (SCLC ... ) Staging SCLC has ... #Lung #Cancer #SCLC
Diagnostic Algorithm for Non–Small-Cell Lung Cancer (NSCLC). The upper portion of the algorithm shows the morphologic
Non–Small-Cell Lung Cancer (NSCLC ... classification of NSCLC ... Honc #Algorithm #NSCLC ... #PDL1 #NEJM
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Trials - EGDT: NEJM ... - ProCESS: NEJM ... 2014 - ARISE: NEJM ... - ProMlSe: NEJM ... Therapy #Trials #EBM